Ignite Creation Date:
2025-12-24 @ 4:58 PM
Ignite Modification Date:
2026-01-06 @ 9:51 PM
Study NCT ID:
NCT01127750
Status:
COMPLETED
Last Update Posted:
2017-02-23
First Post:
2010-05-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients
Sponsor:
Novartis
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CFTY720D2316
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None